Sector ratings ALK-Abelló A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 10/07/2026 BST			5-day change	1st Jan Change
242.60 ^DKK	-0.25%		-0.57%	+6.12%

06-15	ALK Receives UK Approval For EURneffy 1 Mg As The First And Only Needle-Free Adrenaline Treatment For Young Children At Risk Of Anaphylaxis	CI
06-15	UK Regulator OKs Lower Dose of ALK-Abelló's Severe Allergic Reaction Treatment	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
ALK-ABELLÓ A/S	8.24B	BBB
ELI LILLY AND COMPANY	1,085B	A
JOHNSON & JOHNSON	624B	BBB
ABBVIE INC.	442B	AA	-
ROCHE HOLDING AG	332B	AA
NOVARTIS AG	282B	AAA
ASTRAZENECA PLC	277B	A
NOVO NORDISK A/S	217B	A
AMGEN INC.	196B	A
GILEAD SCIENCES, INC.	167B	AA
PFIZER INC.	138B	A
VERTEX PHARMACEUTICALS INCORPORATED	126B	AA
BRISTOL-MYERS SQUIBB COMPANY	118B	A
SANOFI	105B	AA
GSK PLC	105B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.59B	AA
BAYER AG	56.94B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.53B	AA
HALEON PLC	42.54B	AA
Average	225.14B	AA
Weighted average by Cap.		AA